2025
Watson, R., Wassersug, R., & Schellhammer, P. (2025, May). IP26-37 The case for, and challenges to, using transdermal estradiol for androgen deprivation therapy. The Journal of Urology, 213(5S), e1374. https://doi.org/10.1097/01.JU.0001110200.18879.65.37
2020 – 2024
Crawford, E. D., Garnick, M. B., Eckel, R. H., Miner, M. M., Freedland, S. J., Pachynski, R. K., … Hafron, J. M. (2024). A proposal for the comprehensive care of men on androgen deprivation therapy: Recommendations from the multidisciplinary Prostate Cancer 360 Working Group. Urology Practice, 11(1), 18–29.
Fu, F., Duthie, C. J., Wibowo, E., Wassersug, R. J., & Walker, L. M. (2022). Openness to using an external penile prosthesis for maintaining sexual intimacy by individuals with erectile dysfunction: A cross-sectional study. Sexual Medicine, 10(5), 100559. https://doi.org/10.1016/j.esxm.2022.100559
Mainwaring, J. M., Walker, L. M., Robinson, J. W., Wassersug, R. J., & Wibowo, E. (2021). The psychosocial consequences of prostate cancer treatments on body image, sexuality, and relationships. Frontiers in Psychology, 12, 765315. https://doi.org/10.3389/fpsyg.2021.765315
Mondal, S., Edwards, S., Wibowo, E., Ahmed, H., Wassersug, R. J., Ellis, J., Isaac, M., Dimitriou, D., & Mangar, S. (2022). Evaluating patterns and factors related to sleep disturbances in prostate cancer patients. Healthcare (Basel), 10(5), 832. https://doi.org/10.3390/healthcare10050832
Muermann, M. M., & Wassersug, R. J. (2022). Prostate cancer from a sex and gender perspective: A review. Sexual Medicine Reviews, 10(1), 142–154. https://doi.org/10.1016/j.sxmr.2021.07.004
Palmer-Hague, J. L., Wong, S. T. S., Wassersug, R. J., Kingstone, A., & Wibowo, E. (2021). Hormones and visual attention to sexual stimuli in older men: An exploratory investigation. Aging Male, 24(1), 106–118. https://doi.org/10.1080/13685538.2021.1973652
Walker, L. M., Sears, C. S., Wibowo, E., Robinson, J. W., Matthew, A. G., McLeod, D. L., & Wassersug, R. J. (2024). A non-randomized comparison of online and in-person formats of the Canadian androgen deprivation therapy educational program: Impacts on side effects, bother, and self-efficacy. Current Oncology, 31(9), 5040–5056. https://doi.org/10.3390/curroncol31090373
Walker, L. M., Sears, C. S., Booker, R., Glaze, S., Doll, C., Phan, T., Brennan, K., & Robinson, J. W. (2021). Perspectives of health care providers referring patients to a newly implemented sexual health program in a Canadian cancer center. Supportive Care in Cancer, 29(12), 7131–7134. https://doi.org/10.1007/s00520-021-06289-4
Walker, L. M., Sears, C. S., Booker, R., Doll, C., Glaze, S., Phan, T., Brennan, K., Millman, R. D., & Robinson, J. W. (2021). Development, implementation, and evaluation of a multidisciplinary oncology sexual health clinic in a Canadian cancer care setting. Journal of Cancer Survivorship, 15(5), 755–766. https://doi.org/10.1007/s11764-020-00967-8
Wassersug, R. J., Schellhammer, P. F., & Wibowo, E. (2024). Re: Christopher J. Logothetis, Andrew W. Hahn. Challenging the prevailing therapeutic dogma for prostate cancer: The case for an overlap syndrome. European Urology, 85(6), e173–e174. https://doi.org/10.1016/j.eururo.2024.02.022
Wibowo, E., Wong, S. T. S., Wassersug, R. J., & Johnson, T. W. (2021). Sexual function after voluntary castration. Archives of Sexual Behavior, 50(8), 3889–3899. https://doi.org/10.1007/s10508-021-02094-6
Wibowo, E., Wassersug, R. J., Robinson, J. W., Matthew, A., McLeod, D., & Walker, L. M. (2019). How are patients with prostate cancer managing androgen deprivation therapy side effects? Clinical Genitourinary Cancer, 17(3), e408–e419. https://doi.org/10.1016/j.clgc.2018.12.006
Pre-2020
Elliott, S., Latini, D. M., Walker, L. M., Wassersug, R., Robinson, J. W., & ADT Survivorship Working Group. (2010). Androgen deprivation therapy for prostate cancer: Recommendations to improve patient and partner quality of life. The Journal of Sexual Medicine, 7(9), 2996–3010. https://doi.org/10.1111/j.1743-6109.2010.01957.x
Elliott, S., Latini, D. M., Walker, L. M., Wassersug, R., Robinson, J. W., & ADT Survivorship Working Group. (2010). Androgen deprivation therapy for prostate cancer: Recommendations to improve patient and partner quality of life. The Journal of Sexual Medicine, 7(9), 2996–3010.
Hamilton, L. D., Van Dam, D., & Wassersug, R. J. (2016). The perspective of prostate cancer patients and patients’ partners on the psychological burden of androgen deprivation and the dyadic adjustment of prostate cancer couples. Psycho‐Oncology, 25(7), 823–831.
McLeod, D. L., Walker, L. M., Wassersug, R. J., Matthew, A., & Robinson, J. W. (2014). The sexual and other supportive care needs of Canadian prostate cancer patients and their partners: Defining the problem and developing interventions. Canadian Oncology Nursing Journal / Revue Canadienne de Soins Infirmiers en Oncologie, 24(4), 272–278.
Donovan, K. A., Walker, L. M., Wassersug, R. J., Thompson, L. M., & Robinson, J. W. (2015). Psychological effects of androgen‐deprivation therapy on men with prostate cancer and their partners. Cancer, 121(24), 4286–4299.
Rot, I., Ogah, I., & Wassersug, R. J. (2012). The language of prostate cancer treatments and implications for informed decision making by patients. European Journal of Cancer Care, 21(6), 766–775.
Rot, I., Wassersug, R. J., & Walker, L. M. (2016). What do urologists think patients need to know when starting on androgen deprivation therapy? The perspective from Canada versus countries with lower gross domestic product. Translational Andrology and Urology, 5(2), 235.
Tran, S., Walker, L. M., Wassersug, R. J., Matthew, A. G., McLeod, D. L., & Robinson, J. W. (2014). What do Canadian uro-oncologists believe patients should know about androgen deprivation therapy? Journal of Oncology Pharmacy Practice, 20(3), 199–209.
Tsang, V. W., Skead, C., Wassersug, R. J., & Palmer-Hague, J. L. (2019). Impact of prostate cancer treatments on men’s understanding of their masculinity. Psychology of Men & Masculinities, 20(2), 214.
Van Dam, D., Wassersug, R. J., & Hamilton, L. D. (2016). Androgen deprivation therapy’s impact on the mood of prostate cancer patients as perceived by patients and the partners of patients. Psycho‐Oncology, 25(7), 848–856.
Walker, L. M., Tran, S., Wassersug, R. J., Thomas, B., & Robinson, J. W. (2013, October). Patients and partners lack knowledge of androgen deprivation therapy side effects. Urologic Oncology: Seminars and Original Investigations, 31(7), 1098–1105.
Walker, L. M., Wassersug, R. J., & Robinson, J. W. (2015). Psychosocial perspectives on sexual recovery after prostate cancer treatment. Nature Reviews Urology, 12(3), 167–176.
Wassersug, R. J., Lyons, A., Duncan, D., Dowsett, G. W., & Pitts, M. (2013). Diagnostic and outcome differences between heterosexual and nonheterosexual men treated for prostate cancer. Urology, 82(3), 565–571.
Wassersug, R. J., Westle, A., & Dowsett, G. W. (2017). Men’s sexual and relational adaptations to erectile dysfunction after prostate cancer treatment. International Journal of Sexual Health, 29(1), 69–79.
Wassersug, R., & Wibowo, E. (2017). Non-pharmacological and non-surgical strategies to promote sexual recovery for men with erectile dysfunction. Translational Andrology and Urology, 6(Suppl 5), S776–S794. https://doi.org/10.21037/tau.2017.04.09
Wibowo, E., Calich, H. J., Currie, R. W., & Wassersug, R. J. (2015). Prolonged androgen deprivation may influence the autoregulation of estrogen receptors in the brain and pelvic floor muscles of male rats. Behavioural Brain Research, 286, 128–135. https://doi.org/10.1016/j.bbr.2015.03.003
Wibowo, E., Deurveilher, S., Wassersug, R. J., & Semba, K. (2012). Estradiol treatment modulates spontaneous sleep and recovery after sleep deprivation in castrated male rats. Behavioural Brain Research, 226(2), 456–464. https://doi.org/10.1016/j.bbr.2011.09.045
Wibowo, E., Pollock, P. A., Hollis, N., & Wassersug, R. J. (2016). Tamoxifen in men: A review of adverse events. Andrology, 4(5), 776–788. https://doi.org/10.1111/andr.12197
Wibowo, E., Schellhammer, P., & Wassersug, R. J. (2011). Role of estrogen in normal male function: Clinical implications for patients with prostate cancer on androgen deprivation therapy. The Journal of Urology, 185(1), 17–23. https://doi.org/10.1016/j.juro.2010.08.094
Wibowo, E., & Wassersug, R. J. (2013). The effect of estrogen on the sexual interest of castrated males: Implications to prostate cancer patients on androgen-deprivation therapy. Critical Reviews in Oncology / Hematology, 87(3), 224–238. https://doi.org/10.1016/j.critrevonc.2013.01.006
Wibowo, E., & Wassersug, R. J. (2013). Does the timing of estrogen administration after castration affect its ability to preserve sexual interest in male rats? Exploring the critical period hypothesis. Physiology & Behavior, 110–111, 63–72. https://doi.org/10.1016/j.physbeh.2012.12.010
Wibowo, E., Wassersug, R., Warkentin, K., Walker, L., Robinson, J., Brotto, L., & Johnson, T. (2012). Impact of androgen deprivation therapy on sexual function: A response. Asian Journal of Andrology, 14(5), 793–794. https://doi.org/10.1038/aja.2012.60
Wibowo, E., Wassersug, R. J., Robinson, J. W., Santos-Iglesias, P., Matthew, A., McLeod, D. L., & Walker, L. M. (2020). An educational program to help patients manage androgen deprivation therapy side effects: Feasibility, acceptability, and preliminary outcomes. American Journal of Men’s Health, 14(1), 1557988319898991. https://doi.org/10.1177/1557988319898991
Wibowo, E., Wassersug, R. J., Robinson, J. W., Matthew, A., McLeod, D., & Walker, L. M. (2019). How are patients with prostate cancer managing androgen deprivation therapy side effects? Clinical Genitourinary Cancer, 17(3), e408–e419.
NOT APA
Wibowo E, Wassersug RJ, Robinson JW, Santos-Iglesias P, Matthew A, McLeod DL, Walker LM. An Educational Program to Help Patients Manage Androgen Deprivation Therapy Side Effects: Feasibility, Acceptability, and Preliminary Outcomes. Am J Mens Health. 2020 Jan-Feb;14(1):1557988319898991. doi: 10.1177/1557988319898991.
Tsang, V. W., Skead, C., Wassersug, R. J., & Palmer-Hague, J. L. (2019). Impact of prostate cancer treatments on men’s understanding of their masculinity. Psychology of men & masculinities, 20(2), 214.
Wibowo, E., Wassersug, R. J., Robinson, J. W., Matthew, A., McLeod, D., & Walker, L. M. (2019). How are patients with prostate cancer managing androgen deprivation therapy side effects?. Clinical Genitourinary Cancer, 17(3), e408-e419.
Wassersug, R. J., Westle, A., & Dowsett, G. W. (2017). Men’s sexual and relational adaptations to erectile dysfunction after prostate cancer treatment. International Journal of Sexual Health, 29(1), 69-79.
Wassersug R, Wibowo E. Non-pharmacological and non-surgical strategies to promote sexual recovery for men with erectile dysfunction. Transl Androl Urol. 2017 Nov;6(Suppl5):S776-S794. doi: 10.21037/tau.2017.04.09.
Hamilton, L. D., Van Dam, D., & Wassersug, R. J. (2016). The perspective of prostate cancer patients and patients’ partners on the psychological burden of androgen deprivation and the dyadic adjustment of prostate cancer couples. Psycho‐Oncology, 25(7), 823-831.
Rot, I., Wassersug, R. J., & Walker, L. M. (2016). What do urologists think patients need to know when starting on androgen deprivation therapy? The perspective from Canada versus countries with lower gross domestic product. Translational Andrology and Urology, 5(2), 235.
Van Dam, D., Wassersug, R. J., & Hamilton, L. D. (2016). Androgen deprivation therapy’s impact on the mood of prostate cancer patients as perceived by patients and the partners of patients. Psycho‐Oncology, 25(7), 848-856.
Wibowo E, Pollock PA, Hollis N, Wassersug RJ. Tamoxifen in men: a review of adverse events. Andrology. 2016 Sep;4(5):776-88. doi: 10.1111/andr.12197.
Donovan, K. A., Walker, L. M., Wassersug, R. J., Thompson, L. M., & Robinson, J. W. (2015). Psychological effects of androgen‐deprivation therapy on men with prostate cancer and their partners. Cancer, 121(24), 4286-4299.
Walker, L. M., Wassersug, R. J., & Robinson, J. W. (2015). Psychosocial perspectives on sexual recovery after prostate cancerv treatment. Nature Reviews Urology, 12(3), 167-176.
Wibowo E, Calich HJ, Currie RW, Wassersug RJ. Prolonged androgen deprivation may influence the autoregulation of estrogen receptors in the brain and pelvic floor muscles of male rats. Behav Brain Res. 2015 Jun 1;286:128-35. doi: 10.1016/j.bbr.2015.03.003.
McLeod, D. L., Walker, L. M., Wassersug, R. J., Matthew, A., & Robinson, J. W. (2014). The sexual and other supportive care needs of Canadian prostate cancer patients and their partners: Defining the problem and developing interventions. Canadian Oncology Nursing Journal/Revue canadienne de soins infirmiers en oncologie, 24(4), 272-278.
Tran, S., Walker, L. M., Wassersug, R. J., Matthew, A. G., McLeod, D. L., & Robinson, J. W. (2014). What do Canadian uro-oncologists believe patients should know about androgen deprivation therapy?. Journal of Oncology Pharmacy Practice, 20(3), 199- 209.
Wassersug, R. J., Lyons, A., Duncan, D., Dowsett, G. W., & Pitts, M. (2013). Diagnostic and outcome differences between heterosexual and nonheterosexual men treated for prostate cancer. Urology, 82(3), 565-571.
Wibowo E, Wassersug RJ. The effect of estrogen on the sexual interest of castrated males: Implications to prostate cancer patients on androgen-deprivation therapy. Crit Rev Oncol Hematol. 2013 Sep;87(3):224-38. doi: 10.1016/j.critrevonc.2013.01.006.
Walker, L. M., Tran, S., Wassersug, R. J., Thomas, B., & Robinson, J. W. (2013, October). Patients and partners lack knowledge of androgen deprivation therapy side effects. In Urologic Oncology: Seminars and Original Investigations (Vol. 31, No. 7, pp. 1098-1105). Elsevier.
Wibowo E, Wassersug RJ. Does the timing of estrogen administration after castration affect its ability to preserve sexual interest in male rats?–exploring the critical period hypothesis. Physiol Behav. 2013 Feb 17;110-111:63-72. doi: 10.1016/j.physbeh.2012.12.010.
Wibowo E, Wassersug R, Warkentin K, Walker L, Robinson J, Brotto L, Johnson T. Impact of androgen deprivation therapy on sexual function: a response. Asian J Androl. 2012 Sep;14(5):793-4. doi: 10.1038/aja.2012.60.
Rot, I., Ogah, I., & Wassersug, R. J. (2012). The language of prostate cancer treatments and implications for informed decision making by patients. European journal of cancer care, 21(6), 766-775.
Wibowo E, Deurveilher S, Wassersug RJ, Semba K. Estradiol treatment modulates spontaneous sleep and recovery after sleep deprivation in castrated male rats. Behav Brain Res. 2012 Jan 15;226(2):456-64. doi: 10.1016/j.bbr.2011.09.045.
Wibowo, E., Deurveilher, S., Wassersug, R. J., & Semba, K. (2012). Estradiol treatment modulates spontaneous sleep and recovery after sleep deprivation in castrated male rats. Behavioural brain research, 226(2), 456-464.
Wibowo, E., Wassersug, R., Warkentin, K., Walker, L., Robinson, J., Brotto, L., & Johnson, T. (2012). Impact of androgen deprivation therapy on sexual function: a response. Asian Journal of Andrology, 14(5), 793.
Wibowo E, Schellhammer P, Wassersug RJ. Role of estrogen in normal male function: clinical implications for patients with prostate cancer on androgen deprivation therapy. J Urol. 2011 Jan;185(1):17-23. doi: 10.1016/j.juro.2010.08.094
Elliott, S., Latini, D. M., Walker, L. M., Wassersug, R., Robinson, J. W., & ADT Survivorship Working Group. (2010). Androgen deprivation therapy for prostate cancer: recommendations to improve patient and partner quality of life. The journal of sexual medicine, 7(9), 2996-3010.